Corrigendum to "Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma": [Ann Oncol 35 (2024) 1039-1047]

Affiliations

• ¹ Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea. Electronic address: [email protected].
• ² Department of Haematology and Transplantology, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland.
• ³ Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
• ⁴ Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
• ⁵ Mayo Clinic, Rochester, USA.
• ⁶ Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
• ⁷ Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
• ⁸ Hematology Department, Nantes University Hospital, Nantes, France.
• ⁹ Hematology Oncology National University Hospital, Singapore, Singapore.
• ¹⁰ Department of Hematology, Royal Cornwall Hospital, Truro, UK.
• ¹¹ Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warsaw, Poland.
• ¹² State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
• ¹³ Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China.
• ¹⁴ Department of Medical Oncology, and Clinical Haematology, Olivia Newton-John Cancer Centre, Heidelberg, Australia.
• ¹⁵ Department of Hematology, Lyon Sud Hospital, Lyon, France; Lymphoma Immuno-Biology (LIB) team, Inserm U1111, CIRI, Lyon, France.
• ¹⁶ Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France.
• ¹⁷ Hospital Universitario Quiron Salud Madrid, Madrid, Spain.
• ¹⁸ Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, USA.
• ¹⁹ Hematology Department, Peking Union Medical College Hospital, Beijing, China.
• ²⁰ Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
• ²¹ Copernicus Memorial Hospital, Department of General Hematology, Medical University of Łódź, Łódź, Poland.
• ²² Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy.
• ²³ Regeneron Pharmaceuticals, Inc., Tarrytown, USA.
• ²⁴ Regeneron UK Ltd., Uxbridge, UK.
• ²⁵ Division of Hematology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.